BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bakheet AMH, Zhao C, Chen JN, Zhang JY, Huang JT, Du Y, Gong LP, Bi YH, Shao CK. Improving pathological early diagnosis and differential biomarker value for hepatocellular carcinoma via RNAscope technology. Hepatol Int 2020;14:96-104. [PMID: 31832976 DOI: 10.1007/s12072-019-10006-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Tran M, Yoon S, Teoh M, Andersen S, Lam P, Purdue BW, Raghubar A, Hanson S, Devitt K, Jones K, Walters S, Monkman J, Kulasinghe A, Tuong Z, Soyer H, Frazer IH, Nguyen Q. A robust experimental and computational analysis framework at multiple resolutions, modalities and coverages. Front Immunol 2022;13:911873. [DOI: 10.3389/fimmu.2022.911873] [Reference Citation Analysis]
2 Lu J, Zhao M, Wu C, Chu C, Zhang CZ, Cao Y. Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues. Diagn Pathol 2022;17:10. [PMID: 35027056 DOI: 10.1186/s13000-022-01191-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Atout S, Shurrab S, Loveridge C. Evaluation of the Suitability of RNAscope as a Technique to Measure Gene Expression in Clinical Diagnostics: A Systematic Review. Mol Diagn Ther 2021. [PMID: 34957535 DOI: 10.1007/s40291-021-00570-2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Luo RZ, Chen SL, Li M, Li Y, Yang X, Liu LL. HPV E6/E7 mRNA in situ hybridization in endocervical adenocarcinoma: implications for prognosis and diagnosis. Cancer Cell Int 2021;21:643. [PMID: 34861873 DOI: 10.1186/s12935-021-02349-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Chen R, Qin P, Luo Q, Yang W, Tan X, Cai T, Jiang Q, Chen H. ER-positive endocervical adenocarcinoma mimicking endometrioid adenocarcinoma in morphology and immunohistochemical profile: A case report of application of HPV RNAscope detection. Medicine (Baltimore) 2021;100:e24927. [PMID: 33787580 DOI: 10.1097/MD.0000000000024927] [Reference Citation Analysis]
6 Zhang SW, Luo RZ, Sun XY, Yang X, Yang HX, Xiong SP, Liu LL. Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix. BMC Cancer 2021;21:332. [PMID: 33789601 DOI: 10.1186/s12885-021-08059-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ren X, Dong Y, Duan M, Zhang H, Gao P. Abnormal expression of HNRNPA3 in multistep hepatocarcinogenesis. Oncol Lett 2021;21:46. [PMID: 33281957 DOI: 10.3892/ol.2020.12307] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhu MMT, Shenasa E, Nielsen TO. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials. Cancer Treat Rev 2020;91:102115. [PMID: 33130422 DOI: 10.1016/j.ctrv.2020.102115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
9 Chen F, Ni X, Chen L, Wang X, Xu J. miR-939-3p promotes epithelial-mesenchymal transition and may be used as a prognostic marker in hepatocellular carcinoma. Oncol Lett 2020;19:2727-32. [PMID: 32218824 DOI: 10.3892/ol.2020.11361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]